CN106924445A - 一种辅助睡眠外用生物制剂及其制备方法 - Google Patents
一种辅助睡眠外用生物制剂及其制备方法 Download PDFInfo
- Publication number
- CN106924445A CN106924445A CN201710208252.7A CN201710208252A CN106924445A CN 106924445 A CN106924445 A CN 106924445A CN 201710208252 A CN201710208252 A CN 201710208252A CN 106924445 A CN106924445 A CN 106924445A
- Authority
- CN
- China
- Prior art keywords
- external application
- biological agent
- assisting sleep
- application biological
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000003124 biologic agent Substances 0.000 title claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 239000003381 stabilizer Substances 0.000 claims abstract description 7
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- -1 aqua Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims description 17
- 244000025221 Humulus lupulus Species 0.000 claims description 16
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 16
- 244000126014 Valeriana officinalis Species 0.000 claims description 16
- 235000013832 Valeriana officinalis Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 235000016788 valerian Nutrition 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 10
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 10
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 10
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 8
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- 235000010265 sodium sulphite Nutrition 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 229920002643 polyglutamic acid Polymers 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 229960000458 allantoin Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical class CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical class CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 2
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000019437 butane-1,3-diol Nutrition 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000007921 spray Substances 0.000 abstract description 7
- 239000003623 enhancer Substances 0.000 abstract 1
- 230000003204 osmotic effect Effects 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000005507 spraying Methods 0.000 description 12
- 239000012982 microporous membrane Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 208000019116 sleep disease Diseases 0.000 description 7
- 208000020685 sleep-wake disease Diseases 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000005059 dormancy Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000004620 sleep latency Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- VWNRYDSLHLCGLG-NDNWHDOQSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)C[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O VWNRYDSLHLCGLG-NDNWHDOQSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种辅助睡眠外用生物制剂及其制备方法,该制剂包括如下重量百分比含量的组分:药物成分0.1%~30.0%、稳定剂0.01%~5.0%、多元醇0.5%~30.0%、保湿剂0.01%~5.0%、增稠剂0.1%~10.0%,余量为水。本发明通过加入优选的皮肤促渗剂,使得药物成分得到稳定释放,使人体能够有效吸收,直接通过皮肤作用快速渗透入人体循环系统,大大提高了药物成分的效力,并且可做成喷剂、水剂、膏剂、凝胶、贴剂等形式,直接喷洒或涂抹在皮肤表面,方便患者使用。
Description
技术领域
本发明涉及一种在化妆品、药品、保健品领域,特别涉及一种辅助睡眠外用生物制剂及其制备方法。
背景技术
失眠是一种睡眠障碍性疾病,是多种躯体、精神和行为疾病所具有的常见临床表现。现代社会压力越来越大,失眠症状越来越普遍。长期失眠会导致思维敏捷性降低、记忆力减退和动作迟缓等负面结果,严重影响着人们的身心健康、生活质量和工作效率。
现有的市面上的各种改善失眠症状,以及安神,舒缓压力等功能的药品,保健品,以及化妆品。他们大多以口服形式作用于人体。其中包含的用于改善睡眠的有效成份例如地西泮等,往往易于产生头痛、胃肠道不舒服等副作用,因此,需要增加不同的剂型和不同的给药途径,以满足消费者的不同需求,来克服口服制剂可能产生的副作用。
发明内容
有鉴于此,本发明目的在于提供一种稳定性好、副作用小、皮肤透过性好、应用范围广的辅助睡眠外用生物制剂及其制备方法。
首先,本发明提供一种辅助睡眠外用生物制剂,具体技术方案如下:
一种辅助睡眠外用生物制剂,包括如下重量百分比含量的组分:药物成分0.1%~30.0%、稳定剂0.01%~5.0%、多元醇0.5%~30.0%、保湿剂0.01%~5.0%、增稠剂0.1%~10.0%,余量为水。
优选地,所述药物成分为褪黑素、酪氨酸、γ-氨基丁酸中任意一种的0.1%~10.0%、与缬草(VALERIANA OFFICINALIS)提取物0.1%~10.0%、啤酒花(HUMULUSLUPULUS)提取物的组合物。
优选地,所述稳定剂为抗坏血酸、亚硫酸钠、连二亚硫酸钠中的一种或多种的混合物。
优选地,所述保湿剂为甘油、泛醇、透明质酸钠、聚谷氨酸、神经酰胺、壳聚糖、山梨醇、尿囊素中的一种或多种的混合物。
优选地,所述多元醇为丙二醇、二丙二醇、1,2-己二醇、1,3-丁二醇、1,2-戊二醇中的一种或多种的混合物。
优选地,所述增稠剂为卡波姆、黄原胶、十六-十八醇、明胶、瓜尔胶、阿拉伯胶、羟丙甲基纤维素、羧甲基纤维素钠中的一种或多种的混合物。
优选地,所述药物成分的粒径为10-100nm。
其次,本发明还提供一种上述辅助睡眠外用生物制剂的制备方法,包括如下步骤:
(1)将药物成分中的褪黑素、酪氨酸、γ-氨基丁酸中任意一种研磨至粒径为10-100nm的颗粒,与缬草(VALERIANA OFFICINALIS)提取物、啤酒花(HUMULUS LUPULUS)提取物,水浴搅拌,过滤得到相一,过滤所选滤膜孔径为0.22~1.0μm;
(2)将稳定剂、多元醇、保湿剂、增稠剂与水混合,水浴搅拌、溶解,过滤得到相二,过滤所选滤膜孔径为0.22~1.0μm;
(3)将所述步骤(1)得到的相一与所述步骤(2)所得相二,水浴搅拌,过滤、调节pH值至6~9,得到安眠外用制剂。
上述各步骤中,水浴搅拌的条件为:20~30℃下,以100~300rpm的转速搅拌20min~60min。
本发明中,以上述方法所得的制剂,可用于化妆品、药品、及保健品领域。可做成喷剂、水剂、膏剂、凝胶、贴剂等形式,直接喷洒或涂抹在皮肤表面,方便患者使用。
具体实施方式
以下结合具体实施例,对发明进行详细说明。
本发明中,褪黑素/酪氨酸/γ-氨基丁酸三者的加入方式、及处理方式类似,因此,以下各实施例中,R/S/T表示:R对应褪黑素的试验数据,S对应酪氨酸的试验数据,T对应γ-氨基丁酸的试验数据。
实施例1
将100g褪黑素充分研磨为粒径小于100nm的颗粒,备用;
将100g制备好的褪黑素/酪氨酸/γ-氨基丁酸纳米颗粒,与100g缬草(VALERIANAOFFICINALIS)提取物,100g啤酒花(HUMULUS LUPULUS)提取物,于25℃水浴条件下以200rpm的转速搅拌30min,用0.22μm的微孔滤膜过滤,得到相一,备用;
将12g的卡波姆、20g的甘油,20g的丙二醇,4g的抗坏血酸,以及644g水于25℃水浴条件下搅拌以200rpm的转速搅拌30min,得到相二,备用;
将相一加入相二中,于25℃水浴条件下搅拌以200rpm的转速搅拌60min,再用0.22μm的微孔滤膜过滤,过滤后用NaOH水溶液将pH值调至8-9之间。即得本发明所述的安眠外用凝胶制剂,或贴剂中的药膏部分。
实施例2
将100g褪黑素/酪氨酸/γ-氨基丁酸充分研磨为粒径小于100nm的颗粒,备用;
将100g制备好的褪黑素纳米颗粒,与50g缬草(VALERIANA OFFICINALIS)提取物,50g啤酒花(HUMULUS LUPULUS)提取物,于25℃水浴条件下以200rpm的转速搅拌30min,用0.22μm的微孔滤膜过滤,得到相一,备用;
将8g的黄原胶、10g的透明质酸钠,20g的丙二醇,5g的亚硫酸钠,以及757g水于25℃水浴条件下搅拌以200rpm的转速搅拌30min,得到相二,备用;
将相一加入相二中,于25℃水浴条件下搅拌以200rpm的转速搅拌60min,再用0.22μm的微孔滤膜过滤,过滤后用NaOH水溶液将pH值调至6.5。即得本发明所述的安眠外用凝胶制剂,或贴剂中的药膏部分。
实施例3
将100g褪黑素充分研磨为粒径小于100nm的颗粒,备用;
将100g制备好的褪黑素/酪氨酸/γ-氨基丁酸纳米颗粒,与50g缬草(VALERIANAOFFICINALIS)提取物,50g啤酒花(HUMULUS LUPULUS)提取物,于25℃水浴条件下以200rpm的转速搅拌30min,用0.22μm的微孔滤膜过滤,得到相一,备用;
将16g的十六十八醇纸、10g的甘油,20g的丙二醇,5g的亚硫酸钠,搅拌加热至加热至70℃,再缓慢加入749g水于,冷去至25℃,水浴条件下搅拌以200rpm的转速搅拌30min,得到相二,备用;
将相一加入相二中,于25℃水浴条件下搅拌以200rpm的转速搅拌60min,再用0.22μm的微孔滤膜过滤,过滤后用NaOH水溶液将pH值调至7.0。即得本发明所述的 安眠外用膏体制剂,或贴剂中的药膏部分。
实施例4
将50g褪黑素/酪氨酸/γ-氨基丁酸充分研磨为粒径小于100nm的颗粒,备用;
将50g制备好的褪黑素纳米颗粒,与50g缬草(VALERIANA OFFICINALIS)提取物,50g啤酒花(HUMULUS LUPULUS)提取物,于25℃水浴条件下以200rpm的转速搅拌30min,用0.22μm的微孔滤膜过滤,得到相一,备用;
将1g的聚谷氨酸、1g的透明质酸钠,20g的丙二醇,4g的抗坏血酸,以及824g水于25℃水浴条件下搅拌以200rpm的转速搅拌30min,得到相二,备用;
将相一加入相二中,于25℃水浴条件下搅拌以200rpm的转速搅拌60min,再用0.22μm的微孔滤膜过滤,过滤后用NaOH水溶液将pH值调至6.5。即得本发明所述的安眠外用水剂,或喷剂。
本发明产品配方筛选实验:测试案例举例:
实验对象:选择符合美国睡眠障碍联合会(ASDA)制定的睡眠障碍国际分类(ICSD)中有关失眠的诊断标准的失眠患者100例,根据随机数字表将患者分为两组,每组50例。
诊断标准a)在睡眠障碍状态下身体机能减退;b)入睡困难,但在非睡眠时间容易困倦;c)身体紧张度提高(如易激动,肌肉紧张,血管收缩增强);d)睡眠潜伏期延长,睡眠效率降低,惊醒的次数和持续时间增多;e)上诉症状持续4周以上或略少;f)非其他躯体疾病或精神障碍症状的一部分;g)其他睡眠障碍可与之共存,如睡眠不足、睡眠呼吸暂停综合症等。
施药方法:实施例组和对照组的施药方法为在人体外敷部位为颈部、腰部和腹部中的一处或几处,外敷时间为睡眠前20-60分钟左右。统计各实施例组、对照组和空白组的组治疗前后睡眠效率值。
世界卫生组织颁布的国际统一睡眠效率值量化分级标准(计算公式:睡眠效率(%)=实际入睡时间/上床至起床总时间×100。根据WHO最新颁布的睡眠检测法,将睡眠质量分为V级:I级:睡眠效率71%~80%;II级:睡眠效率61%~70%;HI级:睡眠效率51%~60%;IV级:睡眠效率41%~50%;V级:睡眠效率31%~40%。)评定睡质量眠,睡眠效率值越高,睡眠质量越好。
测试第一例:
将100名年龄在45岁到78岁之间的有少眠,或失眠症状的测试对象,分为两组,I组和II组各50名。制作安眠喷雾A和安眠喷雾B,其中安眠喷雾A为本发明所述安眠外用喷剂剂。安眠喷雾B为水和维生素C的安慰剂。
分别对I组使用安眠喷雾A,对II组使用安眠喷雾B。喷洒部位在人体颈部,喷洒次数为4次,每次喷洒200mg左右。待一周后结果显示,
睡眠效率提高5%以内,视为无作用。
睡眠效率提高5-15%以内,视为有一定改善。
睡眠效率提高15%以上,视为有明显改善。
表1测试第一例的结果
无作用 | 有一定改善 | I级 | 有效率 | |
I组 | 14/24/18 | 16/17/17 | 20/9/15 | 72%/52%/64% |
II组 | 42/43/44 | 8/7/6 | 0/0/0 | 16%/14%/12% |
测试结果说明,本发明所述安眠外用直接对于中老年睡眠障碍者有效率明显,约为72%左右。
测试第二例:
将100名年龄在22岁到34岁之间的有少眠,或失眠症状的测试对象,分为两组,I组和II组各50名。制作安眠喷雾A和安眠喷雾B,其中安眠喷雾A为本发明所述安眠外用喷剂剂。安眠喷雾B为水和维生素C的安慰剂。
分别对I组使用安眠喷雾A,对II组使用安眠喷雾B。喷洒部位在人体颈部,喷洒次数为4次,每次喷洒200mg左右。待一周后结果显示,
睡眠效率提高5%以内,视为无作用。
睡眠效率提高5-15%以内,视为有一定改善。
睡眠效率提高15%以上,视为有明显改善。
表2测试第二例的结果
无作用 | 有一定改善 | 明显改善 | 有效率 | |
I组 | 26/37/30 | 9/7/14 | 15/6/6 | 48%/26%/40% |
II组 | 47/46/45 | 3/4/5 | 0/0/0 | 6%/8%/10% |
测试结果说明,本发明所述安眠外用直接对于青年睡眠障碍者有效率明显,约为48%/26%/40%左右,但较中老年睡眠障碍者略低一些。
测试第三例:
使用实施例1~4制备的凝胶剂,水剂,或喷剂涂抹于叙利亚白鼠皮肤表面,静置4小时后,观察有无充血、红肿现象,说明本发明提供的安眠外用制剂是否对皮肤有刺激性。
表3实施例1~4纳米组合物及空白组皮肤刺激性观察结果
“+”叙利亚白鼠皮肤充血、红肿;“++”表示充血、红肿现象仍在,但有增加趋势;“-”表示无充血、红肿现象。
由以上测试结果可知,本发明提供的安眠外用制剂稳定性好、副作用小,对皮肤无刺激,可明显改善睡眠品质。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明披露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (8)
1.一种辅助睡眠外用生物制剂,其特征在于,包括如下重量百分比含量的组分:药物成分0.1%~30.0%、稳定剂0.01%~5.0%、多元醇0.5%~30.0%、保湿剂0.01%~5.0%、增稠剂0.1%~10.0%,余量为水。
2.根据权利要求1所述的辅助睡眠外用生物制剂,其特征在于,所述药物成分为褪黑素、酪氨酸、γ-氨基丁酸中任意一种的0.1%~10.0%、与缬草(VALERIANA OFFICINALIS)提取物0.1%~10.0%、啤酒花(HUMULUS LUPULUS)提取物的组合物。
3.根据权利要求1所述的辅助睡眠外用生物制剂,其特征在于,所述稳定剂为抗坏血酸、亚硫酸钠、连二亚硫酸钠中的一种或多种的混合物。
4.根据权利要求1所述的辅助睡眠外用生物制剂,其特征在于,所述保湿剂为甘油、泛醇、透明质酸钠、聚谷氨酸、神经酰胺、壳聚糖、山梨醇、尿囊素中的一种或多种的混合物。
5.根据权利要求1所述的辅助睡眠外用生物制剂,其特征在于,所述多元醇为丙二醇、二丙二醇、1,2-己二醇、1,3-丁二醇、1,2-戊二醇中的一种或多种的混合物。
6.根据权利要求1所述的辅助睡眠外用生物制剂,其特征在于,所述增稠剂为卡波姆、黄原胶、十六-十八醇、明胶、瓜尔胶、阿拉伯胶、羟丙甲基纤维素、羧甲基纤维素钠中的一种或多种的混合物。
7.根据权利要求2所述的辅助睡眠外用生物制剂,其特征在于,所述药物成分的粒径为10-100nm。
8.一种如权利要求1至7中任一项所述辅助睡眠外用生物制剂的制备方法,包括如下步骤:
(1)将药物成分中的褪黑素、酪氨酸、γ-氨基丁酸中任意一种研磨至粒径为10-100nm的颗粒,与缬草(VALERIANA OFFICINALIS)提取物、啤酒花(HUMULUS LUPULUS)提取物,水浴搅拌,过滤得到相一,过滤所选滤膜孔径为0.22~1.0μm;
(2)将稳定剂、多元醇、保湿剂、增稠剂与水混合,水浴搅拌、溶解,过滤得到相二,过滤所选滤膜孔径为0.22~1.0μm;
(3)将所述步骤(1)得到的相一与所述步骤(2)所得相二,水浴搅拌,过滤、调节pH值至6~9,得到安眠外用制剂。
其中,上述各步骤中水浴搅拌的条件为:20~30℃下,以100~300rpm的转速搅拌20min~60min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710208252.7A CN106924445A (zh) | 2017-03-31 | 2017-03-31 | 一种辅助睡眠外用生物制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710208252.7A CN106924445A (zh) | 2017-03-31 | 2017-03-31 | 一种辅助睡眠外用生物制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106924445A true CN106924445A (zh) | 2017-07-07 |
Family
ID=59424942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710208252.7A Pending CN106924445A (zh) | 2017-03-31 | 2017-03-31 | 一种辅助睡眠外用生物制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106924445A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108524316A (zh) * | 2018-07-18 | 2018-09-14 | 张永 | 一种美白淡斑组合物及其制备方法 |
CN111374998A (zh) * | 2020-03-16 | 2020-07-07 | 中山市天图精细化工有限公司 | 一种睡眠喷雾组合物气雾剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474551A (zh) * | 2014-12-19 | 2015-04-01 | 广州共禾医药科技有限公司 | 褪黑素磷脂复合物、其透皮给药制剂及其制备方法 |
CN105687186A (zh) * | 2015-12-31 | 2016-06-22 | 卢秋妤 | 一种安眠外用药物制剂及其制备方法 |
-
2017
- 2017-03-31 CN CN201710208252.7A patent/CN106924445A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474551A (zh) * | 2014-12-19 | 2015-04-01 | 广州共禾医药科技有限公司 | 褪黑素磷脂复合物、其透皮给药制剂及其制备方法 |
CN105687186A (zh) * | 2015-12-31 | 2016-06-22 | 卢秋妤 | 一种安眠外用药物制剂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108524316A (zh) * | 2018-07-18 | 2018-09-14 | 张永 | 一种美白淡斑组合物及其制备方法 |
CN111374998A (zh) * | 2020-03-16 | 2020-07-07 | 中山市天图精细化工有限公司 | 一种睡眠喷雾组合物气雾剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105748315B (zh) | 一种修复皮肤屏障的组合物 | |
CN105662916B (zh) | 一种皮脂膜修复组合物 | |
CN106466454A (zh) | 一种预防及治疗妇科炎症的凝胶剂 | |
CN105726366B (zh) | 皮脂膜修复组合物 | |
CN106924445A (zh) | 一种辅助睡眠外用生物制剂及其制备方法 | |
CN106389139A (zh) | 一种祛痘消痕护肤多功能制剂及其制备方法 | |
CN106333909B (zh) | 一种淡化面部红血丝修复肌肤的乳液及其制备方法 | |
CN105106068B (zh) | 安神香水 | |
CN101011419B (zh) | 一种蜂胶制剂及其制备方法 | |
CN108686023A (zh) | 一种治疗老年性皮肤瘙痒的止痒润肤精油 | |
CN107088169A (zh) | 婴儿润肤霜 | |
CN104188872A (zh) | 一种环保滋润型水性指甲油及其制备方法 | |
CN103341074A (zh) | 抑眩宁颗粒在制备治疗失眠药物中的应用 | |
CN104256651B (zh) | 改善男性性功能的组合物及其制备方法和应用 | |
CN105687186A (zh) | 一种安眠外用药物制剂及其制备方法 | |
CN106805610A (zh) | 一种含有绿茶的保健枕头 | |
CN105395899A (zh) | 天麻的外用剂型 | |
CN1327836C (zh) | 治疗白癜风用组合物 | |
CN101053602B (zh) | 一种治疗口腔溃疡的药物及其制备方法 | |
CN106943444A (zh) | 一种治疗皮肤病的药物组合物及其制备方法和用途 | |
WO2018082163A1 (zh) | 一种抑菌液 | |
CN102366501A (zh) | 一种改善睡眠的自热式中药贴膏剂 | |
CN102366471B (zh) | 一种温补肾虚的自热式中药贴膏剂 | |
CN100496512C (zh) | 珍珠混悬液 | |
CN107412711A (zh) | 一种用于蚊虫叮咬的中药组合物、其制备方法及其新用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170707 |